Liver drug trial halted after just 3 patients
NCT ID NCT06987968
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called VS-01 for people with severe confusion caused by liver disease (overt hepatic encephalopathy). The trial planned to enroll many participants but was stopped early after only 3 people joined. Researchers wanted to see if VS-01 could help patients recover faster when added to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VS-01
- What this could lead to
- If it works, this could point toward a new treatment for severe liver-related confusion (hepatic encephalopathy).
- What could go wrong
- The trial was terminated early with only 3 participants, so there is very little data. It is unclear if VS-01 is safe or effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
96 Jonathan Lucas St, CSB (Main Hospital), Suite 908
Charleston, South Carolina, 29425, United States
-
Georgian Clinics" Kutaisi Referral Hospital 2, Otskheli str.
Kutaisi, 4600, Georgia
-
LEPL The First University Clinic of Tbilisi State, Medical University, Gudamakari str.4,,LEPL The First University Clinic
Tbilisi, 0141, Georgia
-
LLC Geo Hospitals Tbilisi, Multiprofile Medical Center, Tsinandali ,str. 9/3
Tbilisi, 0144, Georgia
-
Nouvel Hôpital Civil, Service de Medecine Intensive Reanimation, 1, place de l'Hôpital
Strasbourg, 67091, France
-
Tbilisi State Medical University and Ingorokva, High Medical Technology University Clinic, Tsinandali Street
Tbilisi, 0144, Georgia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Better crystal ball for liver crisis: new scores put to the test
- Bringing the hospital home: a new model for End-Stage liver care
- Can tracking hospital care for liver patients reduce repeat admissions?
- Could a poop pill protect the liver? trial tests fecal transplants against cirrhosis complications